AMBEV S.A. current report, Q3 FY2017

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of July 2017, with the report filed on August 10, 2017. The document serves as a compliance report under Article 11 of CVM Instruction #358/2002, detailing specific transactions involving the company's own securities, derivatives, and treasury shares.

Key Financial Metrics and Transactions

The filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. Instead, it details the following capital market activities:

  • Treasury Shares (Common):
    • Initial Balance: 10,438,917 shares (0.0664% of total shares).
    • Conversions to ADRs: 43,461 shares converted (July 28 and 31).
    • Option Exercises (Sales): 411,379 shares sold via option exercises totaling R$ 1,784,986.40.
    • Share Acquisition Plan (Buys): 67,773 shares purchased totaling R$ 1,266,030.91.
    • Final Balance: 10,051,850 shares (0.0640% of total shares).
  • ADRs (Common):
    • Conversions: 43,461 ADRs created from common shares.
    • Acquisitions: 145,609 ADRs purchased under the Share Acquisition Plan for USD 881,210.60.
    • Option Exercises: 189,070 ADRs sold via option exercises for USD 881,210.60.
    • Final Balance: 0 ADRs held in treasury.
  • Derivatives (Total Return Swap):
    • Entity: Ambev Luxembourg S.à.r.l.
    • Transaction: Conclusion of a Total Return Swap on July 31, 2017.
    • Notional Quantity: 1,775,000 shares.
    • Volume: USD 34,079,822.50 (based on a price of USD 19.1999).

Material Changes

The filing reports a net reduction in the company's treasury holdings of common shares, decreasing from 10,438,917 to 10,051,850 shares. This change resulted from a combination of share conversions to ADRs, option exercises, and the company's share acquisition plan. The filing does not provide comparative data for the prior period to assess material changes in volume or value trends.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors. It is strictly a regulatory disclosure of securities transactions. The document notes that the reported swap quantity represents an economic exposure rather than an actual purchase or sale of shares.

Investor Verification Checklist

  • Verify the impact of the 411,379 shares sold via option exercises on the company's diluted share count.
  • Confirm the purpose and terms of the Total Return Swap concluded by Ambev Luxembourg S.à.r.l. for 1.775 million shares.
  • Review the company's ongoing Share Acquisition Plan to understand the strategy behind the 67,773 shares purchased in July.
  • Check subsequent filings for the final settlement details of the swap transaction reported as concluded on July 31, 2017.